- Home
- REPL vs GOOS Comparison
REPL vs GOOS Comparison
Compare REPL & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- GOOS
- Stock Information
- Founded
- REPL 2015
- GOOS 1957
- Country
- REPL United States
- GOOS Canada
- Employees
- REPL N/A
- GOOS N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- GOOS
- Sector
- REPL Health Care
- GOOS
- Exchange
- REPL Nasdaq
- GOOS Nasdaq
- Market Cap
- REPL 897.3M
- GOOS 927.4M
- IPO Year
- REPL 2018
- GOOS 2017
- Fundamental
- Price
- REPL $12.49
- GOOS $10.13
- Analyst Decision
- REPL Strong Buy
- GOOS Hold
- Analyst Count
- REPL 6
- GOOS 5
- Target Price
- REPL $17.50
- GOOS $11.25
- AVG Volume (30 Days)
- REPL 1.3M
- GOOS 976.8K
- Earning Date
- REPL 02-06-2025
- GOOS 01-30-2025
- Dividend Yield
- REPL N/A
- GOOS N/A
- EPS Growth
- REPL N/A
- GOOS 24.08
- EPS
- REPL N/A
- GOOS 0.48
- Revenue
- REPL N/A
- GOOS $981,028,605.00
- Revenue This Year
- REPL N/A
- GOOS $1.66
- Revenue Next Year
- REPL $300.41
- GOOS $5.75
- P/E Ratio
- REPL N/A
- GOOS $20.78
- Revenue Growth
- REPL N/A
- GOOS 7.12
- 52 Week Low
- REPL $4.92
- GOOS $9.23
- 52 Week High
- REPL $17.00
- GOOS $14.75
- Technical
- Relative Strength Index (RSI)
- REPL 50.53
- GOOS 56.90
- Support Level
- REPL $11.19
- GOOS $9.82
- Resistance Level
- REPL $12.79
- GOOS $10.31
- Average True Range (ATR)
- REPL 0.70
- GOOS 0.36
- MACD
- REPL -0.14
- GOOS 0.06
- Stochastic Oscillator
- REPL 52.21
- GOOS 81.15
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of functional and fashionable retailers, including major luxury department stores, outdoor specialty stores, individual shops, and international distributors. Geographically, it has a presence in Canada, the United States, Asia, Europe, and the Rest of the World.